View Ontology Report


Repaglinide is an anti-diabetic drug used as a blocker of the ATP-sensitive potassium channels (KATP) to promote insulin secretion and lower blood glucose levels in patients with type 2 diabetes mellitus (T2D). In response to elevated levels of circulating glucose; insulin is secreted from the pancreatic beta cells. This effect is counteracted by glucagon when the glucose levels are low - the two hormones act to maintain glucose homeostasis. The secre

Pathway Diagram:

Ariadne Genomics Inc. uptaken repaglinide CYP3A4 ---> repaglinide metabolites repaglinide metabolites ---> repaglinide and metabolites excretion repaglinide repaglinide ---> uptaken repaglinide repaglinide and metabolites excretion repaglinide metabolites CYP2C8 ---> repaglinide metabolites CYP3A4 SLCO1B1 CYP2C8

Genes in Pathway:

show annotations for term's descendants       view all columns           Sort by:

Additional Elements in Pathway:

(includes Gene Groups, Small Molecules, Other Pathways..etc.)
Object TypePathway ObjectPathway Object Description
Small Moleculerepagliniderepaglinide

Pathway Gene Annotations

References Associated with the repaglinide pharmacokinetics pathway:

Ontology Path Diagram:

paths to the root

Import into Pathway Studio: